Generic, Branded Generic & Proprietary Medicinal Products - Group 12
A Contract Award Notice
by BUSINESS SERVICES ORGANISATION, PROCUREMENT AND LOGISTICS SERVICE
- Source
- OJEU
- Type
- Contract (Supply)
- Duration
- 5 year (est.)
- Value
- £11M
- Sector
- HEALTH
- Published
- 06 Oct 2023
- Delivery
- To 14 Dec 2030 (est.)
- Deadline
- n/a
Concepts
Location
Belfast
2 buyers
31 suppliers
- Accord Barnstaple
- Aguettant Bristol
- Aop Orphan Birmingham
- Aspen Pharmacare London
- B Braun Medical Sheffield
- Bayer Newbury
- Bowmed Ibisqus Wrexham
- Chiesi Cheadle
- DR Falk Pharma Bourne End
- Esteve Pharmaceuticals Maidenhead
- Flexipharm Austrading St Albans
- Galen Craigavon
- Glaxosmithkline Brentford
- Hameln Pharma Gloucester
- Iskus Health County Dublin
- Janssen Cilag High Wycombe
- Lupin Healthcare High Wycombe
- Macarthys Laboratories Romford
- Morningside Pharmaceuticals Loughborough
- Napp Pharmaceuticals Cambridge
- Neon Healthcare Ware
- Novartis Pharmaceuticals Camberley
- Pfizer Sandwich
- Rosemont Pharmaceuticals Leeds
- Takeda Bucks
- Thornton & Ross Huddersfield
- Tillomed Laboratories Luton
- Torbay Pharmaceuticals Paignton
- Viatris UK Healthcare Potters Bar
- Wockhardt UK Holdings Wrexham
- Zentiva Pharma Guildford
Description
Generic, Branded Generic & Proprietary Medicinal Products - Group 12
Total Quantity or Scope
Generic, Branded Generic & Proprietary Medicinal Products - Group 12 [4724006] This Contract is awarded to the following participating bodies (the Client): i. Belfast Health and Social Care Trust (BHSCT) ii. South Eastern Health and Social Care Trust (SEHSCT) iii. Northern Health and Social Care Trust (NHSCT) iv. Southern Health and Social Care Trust (SHSCT) v. Western Health and Social Care Trust (WHSCT) vi. Business Services Organisation (BSO) vii. Regional Pharmaceutical Procurement Service (RPhPS) viii. Northern Ireland Ambulance Service (NIAS) ix. Northern Ireland Blood Transfusion Service (NIBTS) x. Public Health Agency (PHA) xi. Department of Health, Northern Ireland (DoH(NI))
Award Detail
1 | Accord (Barnstaple)
|
2 | Aguettant (Bristol)
|
3 | Aop Orphan (Birmingham)
|
4 | Aspen Pharmacare (London)
|
5 | B Braun Medical (Sheffield)
|
6 | Bayer (Newbury)
|
7 | Bowmed Ibisqus (Wrexham)
|
8 | Chiesi (Cheadle)
|
9 | DR Falk Pharma (Bourne End)
|
10 | Esteve Pharmaceuticals (Maidenhead)
|
11 | Flexipharm Austrading (St Albans)
|
12 | Galen (Craigavon)
|
13 | Glaxosmithkline (Brentford)
|
14 | Hameln Pharma (Gloucester)
|
15 | Iskus Health (None)
|
16 | Janssen Cilag (High Wycombe)
|
17 | Lupin Healthcare (High Wycombe)
|
18 | Macarthys Laboratories (Romford)
|
19 | Morningside Pharmaceuticals (Loughborough)
|
20 | Napp Pharmaceuticals (Cambridge)
|
21 | Neon Healthcare (Ware)
|
22 | Novartis Pharmaceuticals (Camberley)
|
23 | Pfizer (Sandwich)
|
24 | Rosemont Pharmaceuticals (Leeds)
|
25 | Takeda (Bucks)
|
26 | Thornton & Ross (Huddersfield)
|
27 | Tillomed Laboratories (Luton)
|
28 | Torbay Pharmaceuticals (Paignton)
|
29 | Viatris UK Healthcare (Potters Bar)
|
30 | Wockhardt UK Holdings (Wrexham)
|
31 | Zentiva Pharma (Guildford)
|
Award Criteria
Compliance with Contract Scope and Specification | _ |
Supply and Delivery of Product: Evidence of compliance with Good Distribution Practice (GDP) requirements | _ |
Supply and Delivery of Product: Same Working Day Delivery | 5.0 |
Supply and Delivery of Product: Wholesale Distribution | 5.0 |
Continuity of Supply: Minimum Committed Stockholding | 8.0 |
Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA): Section 1 | _ |
Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA): Section 2 – Section 6 (inclusive) | 40.0 |
PRICE | 40.0 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price and quality.
Other Information
The estimated total value of contract (excluding VAT) is GDP 10507966 to GBP 59107310. This maximum value in the range takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts documents and provides for potential growth of up to 50% over the course of the contract. The total value of contract (detailed in section V.2.4) awarded to each of the contractors indicated in this notice is based on an initial contract period of 24 months. It is important to note that there is available provision to extend this initial contract period in accordance with Section 2 of the SS17bc Commercial Conditions of Contract for Supplies Contracts document.
Reference
- OJEU 601661-2023